MGC Diagnostics Corporation (NASDAQ:MGCD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective March 16, 2017, Wesley W. Winnekins is no longer serving as Chief Financial Officer or an employee of MGC Diagnostics Corporation (the “Company”).

The Company’s Board of Directors has appointed Jill Burchill as Interim Chief Financial Officer effective March 20, 2017. Ms. Burchill (CPA, Inactive) has over 30 years of experience as a financial professional, including serving as chief financial officer or interim chief financial officer for a number of public and private issuers. The Company has agreed to compensate Ms. Burchill on an hourly basis for her services as interim Chief Financial Officer.

About MGC Diagnostics Corporation (NASDAQ:MGCD)

MGC Diagnostics Corporation is a medical technology company. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. The Company operates in the manufacture and sale of cardiorespiratory diagnostic products segment. The Company’s product portfolio provides solutions for disease detection, integrated care, and wellness across the cardiorespiratory healthcare range. The Company sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals and university-based medical centers, among others. The Company’s cardiorespiratory diagnostic products measure flow and respiratory pressures and also analyzes the inhaled and exhaled gases, such as oxygen and carbon dioxide. The Company offers its products in various categories, such as Pulmonary Function Products (PFT), Gas Exchange Testing Products, Cycle Ergometers and Treadmills, and Electronic Medical Records Interfaces.

MGC Diagnostics Corporation (NASDAQ:MGCD) Recent Trading Information

MGC Diagnostics Corporation (NASDAQ:MGCD) closed its last trading session up +0.07 at 8.70 with 3,380 shares trading hands.